Cytosorbents Corp (CTSO) › Shareholders' EquityCytosorbents Corp (CTSO) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.1997: $877.5K1998: $1.58M1999: $100.5K2000: $5.34M2001: $2.33M2002: -$4.37M2003: -$3.91M2004: -$6.97M2005: -$9.76M2006: $2.36M2007: -$104.3K2008: -$3.35M2009: -$5.74M2010: -$8.07M2011: -$10.09M2012: -$11.63M2013: -$14.27M2014: $6.94M2015: $9.85M2016: $1.34M2017: $10.26M2018: $16.93M2019: $3.42M2020: $79.22M2021: $62.58M2022: $35.37M2023: $23.48M2024: $11.11M2025: $5.90M$5.90M1997Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$5.90M-46.9%2024$11.11M-52.7%2023$23.48M-33.6%2022$35.37M-43.5%2021$62.58M-21.0%2020$79.22M+2217.6%2019$3.42M-79.8%2018$16.93M+65.0%2017$10.26M+667.3%2016$1.34M-86.4%2015$9.85M+41.8%2014$6.94M+148.7%2013-$14.27M-22.7%2012-$11.63M-15.2%2011-$10.09M-25.1%2010-$8.07M-40.5%2009-$5.74M-71.6%2008-$3.35M-3107.9%2007-$104.3K-104.4%2006$2.36M+124.2%2005-$9.76M-40.1%2004-$6.97M-78.3%2003-$3.91M+10.7%2002-$4.37M-287.8%2001$2.33M-56.4%2000$5.34M+5211.5%1999$100.5K-93.6%1998$1.58M+80.1%1997$877.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share